Neuehealth CEO sells shares price $233,079

In a latest transaction disclosed in an SEC submitting, George Lawrence Mikan III, the CEO and President of NeueHealth, Inc. (NASDAQ:NEUE), offered 31,798 shares of the corporate’s widespread inventory. The shares have been offered at a weighted common worth of $7.33 per share, totaling roughly $233,079. The transaction comes as NeueHealth, at present valued at roughly $61 million, exhibits robust momentum with a 44% worth return over the previous six months. In line with InvestingPro evaluation, the inventory seems undervalued relative to its Truthful Worth.

The sale was carried out on January 6, 2025, and was a part of a transaction to cowl tax withholding obligations upon the vesting of restricted inventory models, in line with the submitting. Following this transaction, Mikan holds 146,539 shares of NeueHealth instantly.

The shares have been offered in a number of transactions at costs starting from $7.18 to $7.50 per share. Mikan has dedicated to offering additional particulars on the particular sale costs upon request.

In different latest information, RBC Capital has adjusted its outlook on NeueHealth, lowering the inventory goal from $8.00 to $7.00, whereas sustaining a Sector Carry out score. This determination follows NeueHealth’s third-quarter outcomes, which exceeded expectations but additionally revealed a 9.01% year-over-year income decline. Regardless of the income dip, the corporate’s administration workforce confirmed that their steerage stays unchanged.

RBC Capital’s up to date valuation mannequin for the upcoming yr displays the third-quarter outcomes and anticipates the forthcoming fiscal interval. The sustained Sector Carry out score suggests NeueHealth’s inventory is predicted to carry out consistent with sector expectations, indicating a impartial stance on the inventory’s efficiency relative to business friends.

These latest developments present traders with a revised benchmark for NeueHealth’s market valuation, as analyzed by RBC Capital. In line with InvestingPro evaluation, the inventory seems undervalued at present ranges, providing extra key insights for potential traders.

This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.